Trials / Completed
CompletedNCT06083974
Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR Targeted Therapy
Retrospective Study of Metastatic Left Colon and Rectal Cancer as Regard Treatment With Anti_EGFR Targeted Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Colorectal cancer ranks the second lethal cancer and third prevalent malignant tumour worldwide, Despite of different odern modalities for diagnosis,large number of cases diagnosed at metastatic advanced stage . New treatment approach has been discovered habe been discovered making a huge revolution in metastatic colorectal cancer represented by targeted therapy including anti\_EGFR ,anti\_angiogenic and kinase inhibitors .
Detailed description
Retrospective study aims to evaluate the effect of EGFR expression in metastatic colorectal cancer and the outcome of treatment with anti\_EGFR targeted therapy between left colon and rectal cancer
Conditions
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2022-12-30
- Completion
- 2022-12-30
- First posted
- 2023-10-16
- Last updated
- 2023-10-16
Source: ClinicalTrials.gov record NCT06083974. Inclusion in this directory is not an endorsement.